Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Ensure Appropriate Use of Psychotropic Medication

Bellingham, Washington Survey Completed on 07-02-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

The facility failed to ensure that a resident was free from unnecessary psychotropic medication use, specifically Risperidone, without a valid supporting diagnosis. The facility's policy requires all medications to be supported by a documented diagnosis or clinical rationale. Resident 45, who had severe cognitive impairment and a diagnosis of dementia, was observed to be calm, easily redirectable, and not exhibiting psychotic behaviors. Despite this, the resident had an active order for Risperidone for 'dementia with behavioral disturbances.' Staff interviews confirmed that the diagnosis of dementia alone was not appropriate for Risperidone use, and there was no documentation of specific behaviors or attempts at non-pharmacological interventions prior to starting the medication. Further review revealed that the medication was initiated at a previous assisted living facility due to reported behaviors, but the documentation lacked details of alternative interventions or a specific behavioral diagnosis. The facility's monthly psychotropic medication review process failed to identify the inappropriate diagnosis for the medication. Both the pharmacist and the Director of Nursing acknowledged that the diagnosis was not appropriate and that the oversight was not caught during routine audits.

An unhandled error has occurred. Reload 🗙